Ignite Proteomics
About Ignite Proteomics
Ignite Proteomics is a company founded in 2024 was acquired by Aditx Therapeutics in March 2026. It operates as a B2B. Ignite Proteomics offers products and services including 32-analyte Assay, Reverse Phase Protein Array, and Laser Capture Microdissection. Ignite Proteomics operates in a competitive market with competitors including Personalis, OncoDNA, Ultivue, Strata Oncology and RootPath Genomics, among others.
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Aditx Therapeutics
(Mar 13, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ignite Proteomics
Ignite Proteomics offers a comprehensive portfolio of products and services, including 32-analyte Assay, Reverse Phase Protein Array, and Laser Capture Microdissection. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assists physicians with data-driven treatment decisions using protein biomarkers.
Enables proteome assessment for oncology therapeutic development.
Supports targeted proteome analysis in clinical trials.
Funding Insights of Ignite Proteomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ignite Proteomics
Ignite Proteomics has secured backing from 1 investor. Prominent investors backing the company include Aditx Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Immune monitoring solutions are provided to the medical community.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ignite Proteomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ignite Proteomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ignite Proteomics Comparisons
Competitors of Ignite Proteomics
Ignite Proteomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Personalis, OncoDNA, Ultivue, Strata Oncology and RootPath Genomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Genomic and theranostic services for oncology precision medicine are delivered.
|
|
| domain | founded_year | HQ Location |
Provider of test panels for personalized cancer therapies
|
|
| domain | founded_year | HQ Location |
Genetic sequencing is provided for late-stage cancer patients.
|
|
| domain | founded_year | HQ Location |
Immunotherapy platform is developed for personalized cancer treatment.
|
|
| domain | founded_year | HQ Location |
Circulating chromatin is profiled via liquid-biopsy platform for cancer diagnosis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ignite Proteomics
Frequently Asked Questions about Ignite Proteomics
When was Ignite Proteomics founded?
Ignite Proteomics was founded in 2024.
What does Ignite Proteomics do?
Ignite Proteomics specializes in proteomics through a 32-analyte assay that aids physicians in data-driven treatment decisions for oncology. It supports BioPharma partners by using techniques like Reverse Phase Protein Array and laser capture microdissection for therapeutic development. The company focuses on predictive protein biomarkers and collaborates with healthcare professionals.
Who are the top competitors of Ignite Proteomics?
Ignite Proteomics's top competitors include Personalis, OncoDNA and ACT Genomics.
What products or services does Ignite Proteomics offer?
Ignite Proteomics offers 32-analyte Assay, Reverse Phase Protein Array, and Laser Capture Microdissection.
Who are Ignite Proteomics's investors?
Ignite Proteomics has 1 investor. Key investors include Aditx Therapeutics.